Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

Cited In for PubMed (Select 18395098)

1.

Progressive familial intrahepatic cholestasis.

Srivastava A.

J Clin Exp Hepatol. 2014 Mar;4(1):25-36. doi: 10.1016/j.jceh.2013.10.005. Epub 2013 Nov 23. Review.

2.

Bile acid pool dynamics in progressive familial intrahepatic cholestasis with partial external bile diversion.

Jericho HS, Kaurs E, Boverhof R, Knisely A, Shneider BL, Verkade HJ, Whitington PF.

J Pediatr Gastroenterol Nutr. 2015 Mar;60(3):368-74. doi: 10.1097/MPG.0000000000000630.

PMID:
25383786
3.

Pharmacological correction of misfolding of ABC proteins.

Rudashevskaya EL, Stockner T, Trauner M, Freissmuth M, Chiba P.

Drug Discov Today Technol. 2014 Jun;12:e87-94. doi: 10.1016/j.ddtec.2014.03.009. Review.

4.

Intractable itch relieved by 4-phenylbutyrate therapy in patients with progressive familial intrahepatic cholestasis type 1.

Hasegawa Y, Hayashi H, Naoi S, Kondou H, Bessho K, Igarashi K, Hanada K, Nakao K, Kimura T, Konishi A, Nagasaka H, Miyoshi Y, Ozono K, Kusuhara H.

Orphanet J Rare Dis. 2014 Jul 15;9:89. doi: 10.1186/1750-1172-9-89.

5.

Two Cases of Progressive Familial Intrahepatic Cholestasis Type 2 Presenting with Severe Coagulopathy without Jaundice.

Tibesar E, Karwowski C, Hertel P, Scheimann A, Karnsakul W.

Case Rep Pediatr. 2014;2014:185923. doi: 10.1155/2014/185923. Epub 2014 Jun 2.

6.

Diagnosis of ABCB11 gene mutations in children with intrahepatic cholestasis using high resolution melting analysis and direct sequencing.

Hu G, He P, Liu Z, Chen Q, Zheng B, Zhang Q.

Mol Med Rep. 2014 Sep;10(3):1264-74. doi: 10.3892/mmr.2014.2349. Epub 2014 Jun 20.

7.

Mutation detection in cholestatic patients using microarray resequencing of ATP8B1 and ABCB11.

McKay KE, Bruce CK, Hartley JL, Knisely AS, Baumann U, Bockisch SS, Sturm E, Hendriksz CJ, Kelly DA, Macdonald F, Gissen P.

Version 2. F1000Res. 2013 Feb 6 [revised 2013 Mar 20];2:32. doi: 10.12688/f1000research.2-32.v2. eCollection 2013.

8.

Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.

Borad MJ, Champion MD, Egan JB, Liang WS, Fonseca R, Bryce AH, McCullough AE, Barrett MT, Hunt K, Patel MD, Young SW, Collins JM, Silva AC, Condjella RM, Block M, McWilliams RR, Lazaridis KN, Klee EW, Bible KC, Harris P, Oliver GR, Bhavsar JD, Nair AA, Middha S, Asmann Y, Kocher JP, Schahl K, Kipp BR, Barr Fritcher EG, Baker A, Aldrich J, Kurdoglu A, Izatt T, Christoforides A, Cherni I, Nasser S, Reiman R, Phillips L, McDonald J, Adkins J, Mastrian SD, Placek P, Watanabe AT, Lobello J, Han H, Von Hoff D, Craig DW, Stewart AK, Carpten JD.

PLoS Genet. 2014 Feb 13;10(2):e1004135. doi: 10.1371/journal.pgen.1004135. eCollection 2014 Feb.

9.

Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.

Lepist EI, Gillies H, Smith W, Hao J, Hubert C, St Claire RL 3rd, Brouwer KR, Ray AS.

PLoS One. 2014 Jan 30;9(1):e87548. doi: 10.1371/journal.pone.0087548. eCollection 2014.

11.

A novel ABCB11 mutation in an Iranian girl with progressive familial intrahepatic cholestasis.

Saber S, Vazifehmand R, Bagherizadeh I, Kasiri M.

Indian J Hum Genet. 2013 Jul;19(3):366-8. doi: 10.4103/0971-6866.120813.

12.

Clinical application of transcriptional activators of bile salt transporters.

Baghdasaryan A, Chiba P, Trauner M.

Mol Aspects Med. 2014 Jun;37:57-76. doi: 10.1016/j.mam.2013.12.001. Epub 2013 Dec 12. Review.

13.

Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11).

Pedersen JM, Matsson P, Bergström CA, Hoogstraate J, Norén A, LeCluyse EL, Artursson P.

Toxicol Sci. 2013 Dec;136(2):328-43. doi: 10.1093/toxsci/kft197. Epub 2013 Sep 6.

14.

Mechanistic insights into isoform-dependent and species-specific regulation of bile salt export pump by farnesoid X receptor.

Song X, Chen Y, Valanejad L, Kaimal R, Yan B, Stoner M, Deng R.

J Lipid Res. 2013 Nov;54(11):3030-44. doi: 10.1194/jlr.M038323. Epub 2013 Sep 3.

15.

Clinical utility gene card for: progressive familial intrahepatic cholestasis type 2.

Gonzales E, Spraul A, Jacquemin E.

Eur J Hum Genet. 2014 Apr;22(4). doi: 10.1038/ejhg.2013.187. Epub 2013 Aug 28. No abstract available.

16.

Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Godoy P, Hewitt NJ, Albrecht U, Andersen ME, Ansari N, Bhattacharya S, Bode JG, Bolleyn J, Borner C, Böttger J, Braeuning A, Budinsky RA, Burkhardt B, Cameron NR, Camussi G, Cho CS, Choi YJ, Craig Rowlands J, Dahmen U, Damm G, Dirsch O, Donato MT, Dong J, Dooley S, Drasdo D, Eakins R, Ferreira KS, Fonsato V, Fraczek J, Gebhardt R, Gibson A, Glanemann M, Goldring CE, Gómez-Lechón MJ, Groothuis GM, Gustavsson L, Guyot C, Hallifax D, Hammad S, Hayward A, Häussinger D, Hellerbrand C, Hewitt P, Hoehme S, Holzhütter HG, Houston JB, Hrach J, Ito K, Jaeschke H, Keitel V, Kelm JM, Kevin Park B, Kordes C, Kullak-Ublick GA, LeCluyse EL, Lu P, Luebke-Wheeler J, Lutz A, Maltman DJ, Matz-Soja M, McMullen P, Merfort I, Messner S, Meyer C, Mwinyi J, Naisbitt DJ, Nussler AK, Olinga P, Pampaloni F, Pi J, Pluta L, Przyborski SA, Ramachandran A, Rogiers V, Rowe C, Schelcher C, Schmich K, Schwarz M, Singh B, Stelzer EH, Stieger B, Stöber R, Sugiyama Y, Tetta C, Thasler WE, Vanhaecke T, Vinken M, Weiss TS, Widera A, Woods CG, Xu JJ, Yarborough KM, Hengstler JG.

Arch Toxicol. 2013 Aug;87(8):1315-530. doi: 10.1007/s00204-013-1078-5. Epub 2013 Aug 23. Review.

17.

Bile formation and secretion.

Boyer JL.

Compr Physiol. 2013 Jul;3(3):1035-78. doi: 10.1002/cphy.c120027. Review.

18.

Apoptosis and necrosis in the liver.

Guicciardi ME, Malhi H, Mott JL, Gores GJ.

Compr Physiol. 2013 Apr;3(2):977-1010. doi: 10.1002/cphy.c120020. Review.

19.

Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations.

Soroka CJ, Boyer JL.

Mol Aspects Med. 2014 Jun;37:3-14. doi: 10.1016/j.mam.2013.05.001. Epub 2013 May 15. Review.

20.

Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma.

Chen Y, Song X, Valanejad L, Vasilenko A, More V, Qiu X, Chen W, Lai Y, Slitt A, Stoner M, Yan B, Deng R.

Hepatology. 2013 Apr;57(4):1530-41. doi: 10.1002/hep.26187. Epub 2013 Feb 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk